1.
Almakaeva, L. G., Begunova, N. V., Naumenok, L. G., Dolya, V. G., & Almakaev, М. S. (2015). Rozrobka skladu infuziynoho preparatu na osnovi moksyfloksatsynu [Development of composition of infusion medication on basis of moxifloxacin]. Anali Mečnikìvskogo Institutu, 2, 70–73 (in Ukrainian).
2.
Ambulkar, P. S., Ghosh, S. K., Indole, I. V., & Pal, A. K. (2009). Genotoxic and cytotoxic effects of antibacterial drug, ciprofloxacin, on human lymphocytes in vitro. Nepal Medical College Journal, 11(3), 147–151.
3. Bogdan, C. (2011). Regulation of lymphocytes by nitric oxide. Methods in Molecular Biology, 677, 375–393.
4.
Boyum, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scandinavian Journal of Clinical and Laboratory Investigation, 21(97), 77–89.
5.
Bryan, N. S., Bian, K., & Murad, F. (2009). Discovery of the nitric oxide signaling pathway and targets for drug development. Frontiers in Bioscience, 14, 1–18.